<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Desai, Swapna</style></author><author><style face="normal" font="default" size="100%">Wood-Trageser, Michelle</style></author><author><style face="normal" font="default" size="100%">Matic, Jelena</style></author><author><style face="normal" font="default" size="100%">Chipkin, Jaqueline</style></author><author><style face="normal" font="default" size="100%">Jiang, Huaiyang</style></author><author><style face="normal" font="default" size="100%">Bachelot, Anne</style></author><author><style face="normal" font="default" size="100%">Dulon, Jerome</style></author><author><style face="normal" font="default" size="100%">Sala, Cinzia</style></author><author><style face="normal" font="default" size="100%">Barbieri, Caterina</style></author><author><style face="normal" font="default" size="100%">Cocca, Massimiliano</style></author><author><style face="normal" font="default" size="100%">Toniolo, Daniela</style></author><author><style face="normal" font="default" size="100%">Touraine, Philippe</style></author><author><style face="normal" font="default" size="100%">Witchel, Selma</style></author><author><style face="normal" font="default" size="100%">Rajkovic, Aleksandar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency.</style></title><secondary-title><style face="normal" font="default" size="100%">J Clin Endocrinol Metab</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Clin. Endocrinol. Metab.</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adult</style></keyword><keyword><style  face="normal" font="default" size="100%">Aging</style></keyword><keyword><style  face="normal" font="default" size="100%">DNA Damage</style></keyword><keyword><style  face="normal" font="default" size="100%">DNA Repair</style></keyword><keyword><style  face="normal" font="default" size="100%">Female</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Minichromosome Maintenance Proteins</style></keyword><keyword><style  face="normal" font="default" size="100%">Primary Ovarian Insufficiency</style></keyword><keyword><style  face="normal" font="default" size="100%">Sequence Analysis, DNA</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2017 02 01</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">102</style></volume><pages><style face="normal" font="default" size="100%">576-582</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;b&gt;Objective: &lt;/b&gt;To assess the frequency of variants, including biallelic pathogenic variants, in minichromosome maintenance 8 (MCM8) and minichromosome maintenance 9 (MCM9), other genes related to MCM8-MCM9, and DNA damage repair (DDR) pathway in participants with primary ovarian insufficiency (POI).&lt;/p&gt;&lt;p&gt;&lt;b&gt;Design: &lt;/b&gt;MCM8, MCM9, and genes encoding DDR proteins that have been implicated in reproductive aging were sequenced among POI participants.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Setting: &lt;/b&gt;Academic research institution.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Participants: &lt;/b&gt;All were diagnosed with POI prior to age 40 years and presented with elevated follicle-stimulating hormone levels.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Interventions: &lt;/b&gt;None.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Main Outcome Measures: &lt;/b&gt;We identified nucleotide variants in MCM8, MCM9, and genes thought to be involved in the DNA damage response pathway and/or implicated in reproductive aging.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Results: &lt;/b&gt;MCM8 was sequenced in 155 POI participants, whereas MCM9 was sequenced in 151 participants. Three of 155 (2%) participants carried possibly damaging heterozygous variants in MCM8, whereas 7 of 151 (5%) individuals carried possibly damaging heterozygous variants in MCM9. One participant carried a novel homozygous variant, c.1651C&gt;T, p.Gln551*, in MCM9, which is predicted to introduce a premature stop codon in exon 9. Biallelic damaging heterozygous variants in both MCM8 and MCM9 were identified in 1 participant. Of a total of 10 participants carrying damaging heterozygous variants in either MCM8 or MCM9, 2 individuals carried heterozygous damaging variants in genes associated with either MCM8 or MCM9 or the DDR pathway.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Conclusions: &lt;/b&gt;We identified a significant number of potentially damaging and novel variants in MCM8 and MCM9 among participants with POI and examined multiallelic association with variants in DDR and MCM8-MCM9 interactome genes.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/27802094?dopt=Abstract</style></custom1></record></records></xml>